Meng Yuan

10.9k total citations · 2 hit papers
72 papers, 3.4k citations indexed

About

Meng Yuan is a scholar working on Infectious Diseases, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Meng Yuan has authored 72 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 25 papers in Molecular Biology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Meng Yuan's work include SARS-CoV-2 and COVID-19 Research (25 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and COVID-19 Clinical Research Studies (12 papers). Meng Yuan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (25 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and COVID-19 Clinical Research Studies (12 papers). Meng Yuan collaborates with scholars based in United States, China and United Kingdom. Meng Yuan's co-authors include Ian A. Wilson, Nicholas C. Wu, Xueyong Zhu, Chang‐Chun D. Lee, Huibin Lv, Chris Ka Pun Mok, Ray T. Y. So, Hejun Liu, Dennis R. Burton and Deli Huang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Meng Yuan

61 papers receiving 3.4k citations

Hit Papers

A highly conserved crypti... 2020 2026 2022 2024 2020 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
    2020 899 citations Meng Yuan, Nicholas C. Wu et al. Science profile →
  2. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
    2021 196 citations Meng Yuan, Deli Huang et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng Yuan United States 26 2.2k 1.2k 572 411 349 72 3.4k
Renhong Yan China 16 2.8k 1.2× 1.5k 1.2× 270 0.5× 350 0.9× 244 0.7× 33 4.4k
Yingying Guo China 10 2.8k 1.2× 1.1k 0.9× 243 0.4× 365 0.9× 229 0.7× 20 3.9k
Jun Lan China 15 3.7k 1.6× 1.5k 1.2× 402 0.7× 401 1.0× 483 1.4× 36 4.8k
Lu Xia China 3 2.7k 1.2× 934 0.8× 246 0.4× 303 0.7× 227 0.7× 5 3.5k
Yicheng Guo United States 21 2.0k 0.9× 858 0.7× 295 0.5× 264 0.6× 284 0.8× 51 2.6k
Hideki Aihara United States 31 2.6k 1.1× 2.7k 2.3× 255 0.4× 391 1.0× 314 0.9× 117 5.3k
Cody B. Jackson United States 10 2.0k 0.9× 960 0.8× 144 0.3× 318 0.8× 273 0.8× 12 2.9k
Yasunori Watanabe Japan 27 1.5k 0.7× 1.5k 1.2× 707 1.2× 517 1.3× 298 0.9× 93 4.5k

Countries citing papers authored by Meng Yuan

Since Specialization
Citations

This map shows the geographic impact of Meng Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Yuan more than expected).

Fields of papers citing papers by Meng Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Yuan. The network helps show where Meng Yuan may publish in the future.

Co-authorship network of co-authors of Meng Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Yuan. A scholar is included among the top collaborators of Meng Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Yuan. Meng Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Huang, et al.. (2025). Differential Response of Ecosystem Service to Restoration Methods and Restoration Time in Shallow Landslide‐Prone Areas. Land Degradation and Development. 36(9). 3051–3062. 1 indexed citations
2.
Nair, Usha, Ziqi Feng, Charles R. Crain, et al.. (2025). In vivo antibody diversification targeting a conserved coronavirus epitope. The Journal of Experimental Medicine. 222(10).
3.
Lin, Xiaohe, Christopher A. Cottrell, Oleksandr Kalyuzhniy, et al.. (2025). Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial. Proceedings of the National Academy of Sciences. 122(33). e2510163122–e2510163122.
4.
Wang, Min, Meng Yuan, Quanliang Wang, et al.. (2025). Nanocellulose Hybrid Membranes for Green Flexible Electronics: Interface Design and Functional Assemblies. ACS Applied Materials & Interfaces. 17(21). 30365–30401. 2 indexed citations
5.
Hendrickx, Rik, Meng Yuan, Pieter Van Wielendaele, et al.. (2025). Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody. eLife. 13.
6.
Hendrickx, Rik, Meng Yuan, Pieter Van Wielendaele, et al.. (2024). Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody. eLife. 13.
7.
Zhao, Danyang, Meng Yuan, Mei Yang, et al.. (2024). Screening of Cancer-Specific Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma Based on a Proteome Microarray. Molecular & Cellular Proteomics. 23(12). 100872–100872.
8.
Yuan, Meng, Linghang Peng, Deli Huang, et al.. (2024). Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4. Structure. 32(6). 766–779.e7. 4 indexed citations
9.
Yuan, Meng, et al.. (2023). Nitroso-Ene-type Cyclization Toward Diversified Synthesis of Amino Deoxysugars: A Proof of Concept. Organic Letters. 25(11). 1929–1934. 4 indexed citations
10.
Zhang, Jin, Xinxin Liu, Meng Yuan, et al.. (2023). Proteome microarray identifies autoantibody biomarkers for diagnosis of hepatitis B-related hepatocellular carcinoma. Clinica Chimica Acta. 554. 117727–117727. 4 indexed citations
11.
Tan, Timothy J.C., Ruipeng Lei, Meng Yuan, et al.. (2023). High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike. Nature Communications. 14(1). 2003–2003. 18 indexed citations
12.
Dai, Bing, Meng Yuan, Nannan Zhang, & Youjuan Ma. (2023). Research on relationship between charging principle and hearth activity of blast furnace (BF). SHILAP Revista de lepidopterología. 1 indexed citations
13.
Yuan, Meng, Deli Huang, Chang‐Chun D. Lee, et al.. (2021). Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science. 373(6556). 818–823. 196 indexed citations breakdown →
14.
Cai, Qixu, Jingjing Guo, Meng Yuan, et al.. (2020). Pyruvate kinase from Plasmodium falciparum: Structural and kinetic insights into the allosteric mechanism. Biochemical and Biophysical Research Communications. 532(3). 370–376. 12 indexed citations
15.
Yuan, Meng, Hejun Liu, Nicholas C. Wu, et al.. (2020). Structural basis of a shared antibody response to SARS-CoV-2. Science. 369(6507). 1119–1123. 297 indexed citations
16.
Wu, Nicholas C., Meng Yuan, Hejun Liu, et al.. (2020). An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Reports. 33(3). 108274–108274. 95 indexed citations
17.
Wu, Nicholas C., Meng Yuan, Sandhya Bangaru, et al.. (2020). A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody. PLoS Pathogens. 16(12). e1009089–e1009089. 39 indexed citations
18.
Liu, Hejun, Nicholas C. Wu, Meng Yuan, et al.. (2020). Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity. 53(6). 1272–1280.e5. 100 indexed citations
19.
Ory, Virginie, Garrett T. Graham, Meng Yuan, et al.. (2019). Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression. EMBO Reports. 21(1). e48741–e48741. 16 indexed citations
20.
Prueksaritanont, Thomayant, Jerome Hochman, Meng Yuan, et al.. (2004). Renal elimination of a novel and potent αvβ3integrin antagonist in animals. Xenobiotica. 34(11-12). 1059–1074. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renhong Yan Breakdown of academic impact, for papers by Yingying Guo Breakdown of academic impact, for papers by Jun Lan Breakdown of academic impact, for papers by Lu Xia Breakdown of academic impact, for papers by Yicheng Guo Breakdown of academic impact, for papers by Hideki Aihara Breakdown of academic impact, for papers by Cody B. Jackson Breakdown of academic impact, for papers by Yasunori Watanabe
Rankless by CCL
2026